您好,欢迎来到上海士研管理咨询有限公司
士研峰会 士研智库 士研调研
嘉宾信息
张连山
张连山
所属职位: 全球研发总裁
所属公司:

江苏恒瑞医药股份有限公司

德国Tubingen大学获有机化学博士,后赴美国Vanderbilt大学从事博士后研究。在加入恒瑞医药前,张连山博士先后在美国礼来和Marcadia Biotech等国际知名药企担任要职,其中在礼来先后任高级化学家、研究顾问及首席研究科学家等。自1988年至今,他从事多肽方法学和新药研发工作三十余年,在糖尿病治疗药物方面极有造诣;在国际学术期刊上发表学术文章60余篇,申请专利160余项。加入恒瑞医药后,他带领团队研发了一系列具有国际竞争力的创新药,其中8个1类创新药品种已获批上市,多个重磅产品已递交上市申请,180多项临床研究正在国内外开展,研发管线全面覆盖国际热门靶点和存在重大未满足临床需求的疾病领域。 Dr. Lianshan Zhang holds the position of Senior Vice President and Global R&D President of Jiangsu Hengrui Medicine. Hengrui is widely recognized as the domestic leader in pharmaceutical R&D innovation in China. In 2010, Dr. Zhang joined Hengrui and takes the responsibility for R&D strategy and management of dozens of NMEs across the globe. Prior to Hengrui, he was a senior research executive at Marcadia Biotech. From 1998 to 2008, Dr. Zhang was engaged in the discovery and development of peptide/protein therapeutics for the treatment of diabetes and obesity and successfully delivered multiple clinical candidates.  

Dr. Lianshan Zhang obtained his undergraduate degree in Medicinal Chemistry from China Pharmaceutical University and his Ph.D. in Organic Chemistry at the University of Tubingen. He conducted his post-doctoral research at University of Tubingen and Vanderbilt University.


微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务